Impending NewsIn anticipation of the patients update next week we have seen increased volume along with a rising share price which has bolstered confidence in Theralase NMIBC treatment. Various posters have given supporting statements published by Theralase and other groups of medical peers that shows superiority in this treatment to current treatment models. It will be no surprise to see in the upcoming week an unimaginable jump in volume and share price, perhaps the 1 dollar will be breached and the start of Mutual Funds entering this stock, who knows eh!
I think I will be picking up a few more bottles of Champaign as the previous ones have mysteriously evaporated.